Results 161 to 170 of about 1,676,735 (349)

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

Multiple-Streams Focusing-Based Cell Separation in High Viscoelasticity Flow. [PDF]

open access: yesACS Omega, 2022
Feng H   +5 more
europepmc   +1 more source

Differential electrophoretic separation of cells and its effect on cell viability [PDF]

open access: yes
An electrophoretic separation method was applied to the separation of cells. To determine the efficiency of the separation, it was necessary to apply existing methodology and develop new methods to assess the characteristics and functions of the ...
Leise, E. M., Lesane, F.
core   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

open access: yesMolecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski   +19 more
wiley   +1 more source

Fermi liquid viscosity in a finite geometry [PDF]

open access: yes
Forced flow of a Fermi liquid is studied for a cell geometry consisting of two planes with a separation on the order of mean free path. An approximate transport equation is used to derive an integral equation for the velocity profile, which is solved ...
Jaffe, J. E.
core   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

open access: yesMolecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp   +13 more
wiley   +1 more source

A moonlighting role for LysM peptidoglycan binding domains underpins Enterococcus faecalis daughter cell separation. [PDF]

open access: yesCommun Biol, 2023
Salamaga B   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy